Bibliographic information
GuidelineMedical eligibility criteria for contraceptive use, 6th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization
Recommendation
New
Recommendations for use of hormonal contraception for women taking HIV pre-exposure prophylaxis (PrEP). Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs): tenofovir emtricitabine. Women using PrEP can use all hormonal contraceptive methods without restriction
Certainty of evidence
Very low